Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | SHBG | P04278 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL105253 | 1.00 | — | — | |
| SCHEMBL304422 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3617591 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3627047 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3624140 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3619227 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL3622609 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL103931 | 1.00 | — | — | |
| SCHEMBL3618893 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10TP53CYP3A4SHBG | |
| SCHEMBL78474 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111302926-B | Beta-diketone cerium (IV) compound and preparation and application thereof | 湖北固润科技股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| WO-2024041569-A1 | ACYLOXYPHOSPHINE OXIME ESTER COMPOUND SUITABLE FOR DEEP CURING OF UV-VIS LED LIGHT SOURCES, METHOD FOR PREPARING SAME, AND USE THEREOF | 湖北固润科技股份有限公司 | 2024-02-29 | — | — | WO | disclosed |
| US-11718758-B2 | Aqueous dispersion of colored particles | MITSUBISHI PENCIL COMPANY, LIMITED (JP) | 2023-08-08 | — | — | US | disclosed |
| EP-3725854-B1 | COLORED PARTICLE AQUEOUS DISPERSION | MITSUBISHI PENCIL CO (JP) | 2023-07-05 | — | — | EP | disclosed |
| CN-111465662-B | Aqueous dispersion of coloured particles | 三菱铅笔株式会社 | 2023-05-26 | — | — | CN | disclosed |
| CN-112094365-B | Photocurable composition containing infrared absorbing photosensitizer, initiator and alkenyl ether and/or oxetane compound | 湖北固润科技股份有限公司 | 2023-04-25 | — | — | CN | disclosed |
| CN-110563588-B | Mono-or di-cinnamate photoinitiator, and preparation method and application thereof | 湖北固润科技股份有限公司 | 2023-02-17 | — | — | CN | disclosed |
| CN-110563589-B | Mono-or di-methyl cinnamate photoinitiator, and preparation method and application thereof | 湖北固润科技股份有限公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-115505004-A | Acyl phosphine oxide oxime ester compound suitable for deep curing of UV-VIS LED light source and preparation and application thereof | 湖北固润科技股份有限公司 | 2022-12-23 | — | — | CN | disclosed |
| WO-2021241484-A1 | WRITING IMPLEMENT | 三菱鉛筆株式会社 | 2021-12-02 | — | — | WO | disclosed |
| US-20060025596-A1 | Method for deuteration or tritiation of heterocyclic ring | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2006-02-02 | — | — | US | disclosed |
| EP-1561741-A1 | METHOD FOR DEUTERATION OR TRITIATION OF HETEROCYCLIC RING | Wako Pure Chemical Industries, Ltd. (JP) | 2005-08-10 | — | — | EP | disclosed |
| EP-1535889-A1 | METHOD OF DEUTERATING AROMATIC RING | Wako Pure Chemical Industries, Ltd. (JP) | 2005-06-01 | — | — | EP | disclosed |
| EP-1229907-A1 | PREVENTION OF PLAQUE RUPTURE BY ACAT INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2002-08-14 | — | — | EP | disclosed |
| US-6417175-B1 | Phosphonocephem derivatives, process for the preparation of the same, and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2002-07-09 | — | — | US | disclosed |
| WO-2001034127-A1 | PREVENTION OF PLAQUE RUPTURE BY ACAT INHIBITORS | WARNER-LAMBERT COMPANY (US) | 2001-05-17 | — | — | WO | disclosed |
| EP-1043327-A1 | PHOSPHONOCEPHEM DERIVATIVES, PROCESS FOR THE PREPARATION OF THE SAME, AND USE THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2000-10-11 | — | — | EP | disclosed |
| US-5948774-A | EXCELLENT ANTIBACTERIAL ACTIVITIES ON A BROAD RANGE OF GRAM-POSITIVE AND GRAM-NEGATIVE BACTERIA, ESPECIALLY STAPHYLOCOCCUS AUREUS AND METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1999-09-07 | — | — | US | disclosed |
| EP-0828744-A1 | CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996038451-A1 | CEPHEM COMPOUNDS, THEIR PRODUCTION AND USE | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-12-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060025596-A1 | Method for deuteration or tritiation of heterocyclic ring | HRH2, HRH4, HDHD5 | ALDH1A1 1829/4885HSD17B10 161/4885TP53 3400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.